Cudetaxestat
(Fibrosis)
Phase 2
Discovering breakthroughs in fibrosis and neurodegeneration
Discovering breakthroughs in fibrosis and neurodegeneration
Discovering breakthroughs in fibrosis and neurodegeneration
Cudetaxestat
(Fibrosis)
Phase 2
BLD-2184
(Neurodegeneration)
IND Ready
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference
BTIG Biotechnology Conference
New York City
Bringing life changing and revolutionary treatments to patients with fibrotic and neurodegenerative diseases.